Almelo, 15th of January 2022 - Investment company Quadrum Capital has launched its fifth fund in December 2021; Quadrum Investment Fund IV (QIF IV). This internationally oriented fund has a size of 400 million euros and builds on the successful placement and development of its predecessor QIF III. QIF III reached its final closing within six months after introduction due to wide interest from both individual investors and institutional investors.
International growth with EuVECA label
With QIF IV Quadrum aims on mature unlisted mid-market companies from the Netherlands and the Benelux with international growth ambitions. The main focus will be on companies within IT, Tech, Healthcare & Packaging. Just like its previous fund, QIF IV has the EuVECA label granted by the AFM, which means that participation rights can be offered in all Member States of the European Union.
Arjan Hoop, Managing Partner at Quadrum Capital: "We are proud to launch our newest fund and once again the granting of the EuVECA label by the AFM as recognition of our quality and vision for the market. With this fund, we have the opportunity to give new and existing platforms in our portfolio international wings. At the same time it enables us to optimally serve the high demand we receive from investors for new investment opportunities in private equity.
First closing
Given the high level of interest from existing and new investors, Quadrum Capital expects to do the first closing for Quadrum Investment Fund IV early 2022.
Ready for further growth
The launch of Quadrum Investment Fund IV is a solid step forward towards further growth for Quadrum Capital. As a regionally anchored investment company, we will continue to hold on to our entrepreneurial backbone, primarily consisting of (former) entrepreneurs and family offices, complemented by a limited number of institutions. Managing Partner Peter Oostenenk: "We are working hard to further expand our team and professionalize our organization. The better we perform, the better our participations can excel."
*For further information about QIF IV, please contact [email protected] or +31 (0)85 273 83 18. *